Viagra in the Treatment of Primary Dysmenorrhea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions
Dysmenorrhea
Interventions
DRUG

Sildenafil Citrate

A single vaginal dose of sildenafil citrate 100 mg and monitored for 4 hours.

DRUG

Placebo

A single vaginal dose of placebo and monitored for 4 hours.

Trial Locations (1)

Unknown

Nova Gradiska General Hospital, Strossmayerova 17

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT00123162 - Viagra in the Treatment of Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter